Dr. Mohamed Elkasaby, MD

Dr. Elkasaby practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Elkasaby's NPI, 1194374256, was assigned on September 10, 2019. Dr. Elkasaby holds Ohio license 57247864.

Dr. Elkasaby's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Elkasaby's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Elkasaby is also affiliated with University Hospitals Ahuja Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Elkasaby to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elkasaby practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Elkasaby's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Elkasaby is licensed in Ohio.

CMS data shows 509 Medicare services from Dr. Elkasaby across 8 procedure codes in 2024, for 222 Medicare patients. Medicare paid $34,243 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 222 Medicare patients who saw Dr. Elkasaby in 2024. The largest group is 75 to 84, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elkasaby's median patient age at 76, with 55% women.

In 2024, Dr. Elkasaby wrote 726 Medicare Part D claims for 166 patients. 95% of them were for generic drugs. CMS names the drug for 602 of them, across 13 drugs with 11 or more claims each, at $132,213 in total drug cost. In 2023, CMS named 248 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Elkasaby for performance year 2024, reported as part of a group. Dr. Elkasaby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elkasaby as offering telehealth.

CMS Open Payments shows 153 general payments to Dr. Elkasaby from 21 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Eli Lilly and Company paid the most, $54,644.